Blog
Selected Titles
The latest videos and pictures
The latest news and articles
We must use the capacity of the private sector to provide the COVID-19 vaccine
Commander of Corona Countermeasures Headquarters in the Tehran metropolis, noting that today the country’s pharmaceutical industry has reached a very high level.
Senior managers of the Food and Drug Administration visit of Actover Group factories
According to the public relations of Actover Group, on Thursday, February 28, the senior managers of the Food and Drug Administration visited the factories of Actover Group.
Production of more the 600 thousands of Remdesivir vials
“Currently, about 6 million people in the country are constantly taking various drugs of Actoverco” said the director of the Actoverco’s factory.
Inauguration of Actotech pharmaceutical and food accelerator with the presence of Dr. Sattari, Vice President for Science and Technology
According to the public relations of the Actover Group, Dr. Ali Naraghi at the opening of the pharmaceutical and food accelerator said: “This Corporation is the result of thinking about creation of a link between industry and the university.
Actoverco’s attendance at the 9th scientific conference of Diabetes in practice
The 19th Iranian Congress of Gastroenterology and Hepatology was held from November 6 to 8 at the Razi International Conference Center.
We will fulfill our mission
the senior marketing and sales manager of Actero said: “Actero Pharmaceutical factory specialized in the production of cancer drugs and one of the six subcategories of Actover Holding, by the end of this year and operating its solid and injectable drugs production lines.
Interview with the CEO of Actoverco
According to the public relations of Actover Group, Nahaleh Naraghi is the CEO of Actoverco. Actoverco is a leading company in the field of producing high quality drugs in accordance with the latest international standards.
Application of CPB technology in production of Actoverco’s Interferon beta 1-a
According to Actoverco’s Public Relations, we are currently producing the raw material of interferon beta-1a from the cell line in the Actover Group in the Actoverco Biotech factory.
Conferences and Exhibitions
